Please see below for a list of search results.
The HTA’s Board is made up of a Chair and twelve Members:
To ensure that the HTA’s regulatory approach remains relevant, we actively prepare for the future. We do this through our development activities.
Our regulatory approach aims to be in line with the principles of better regulation and the Regulators’ Code. This means that we primarily focus our regulation and resources on areas that involve an inherently greater risk to patient safety and public confidence if standards are not maintained...
Our strategic approach is based on being clear on the risks we are regulating, being proportionate and targeted in regulating those risks, taking into account the role of professional bodies and other regulators, and using the minimum necessary direct intervention to achieve compliance and...
We are now in the third year of a multi-year strategy stemming from a review that took place in 2017. At this time, the HTA undertook a fundamental evaluation of the extent to which our strategic approach protects public and professional confidence in the proper use, and quality and safety of,...
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care, established under the Human Tissue Act 2004.
I am pleased to introduce the Human Tissue Authority’s Strategy for the period 2020-23.
Starting count – payroll
Starting count – non-payroll